TW200413355A - Biologically active vasopressin agonist metabolites - Google Patents
Biologically active vasopressin agonist metabolites Download PDFInfo
- Publication number
- TW200413355A TW200413355A TW092134683A TW92134683A TW200413355A TW 200413355 A TW200413355 A TW 200413355A TW 092134683 A TW092134683 A TW 092134683A TW 92134683 A TW92134683 A TW 92134683A TW 200413355 A TW200413355 A TW 200413355A
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- compound
- patent application
- groups
- scope
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/320,761 US7138393B2 (en) | 1998-07-24 | 2002-12-16 | Biologically active vasopressin agonist metabolites |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200413355A true TW200413355A (en) | 2004-08-01 |
Family
ID=32710746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW092134683A TW200413355A (en) | 2002-12-16 | 2003-12-09 | Biologically active vasopressin agonist metabolites |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7138393B2 (de) |
| EP (1) | EP1572694B1 (de) |
| JP (1) | JP2006514956A (de) |
| CN (1) | CN1745083A (de) |
| AR (1) | AR042467A1 (de) |
| AT (1) | ATE410428T1 (de) |
| AU (1) | AU2003297127A1 (de) |
| BR (1) | BR0317383A (de) |
| CA (1) | CA2508764A1 (de) |
| DE (1) | DE60324018D1 (de) |
| DK (1) | DK1572694T3 (de) |
| ES (1) | ES2312859T3 (de) |
| MX (1) | MXPA05006241A (de) |
| TW (1) | TW200413355A (de) |
| WO (1) | WO2004060894A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
| RU2472539C2 (ru) | 2007-08-06 | 2013-01-20 | Аллерган, Инк. | Способы и устройства для доставки препарата десмопрессина |
| PL3085381T3 (pl) | 2008-05-21 | 2018-09-28 | Ferring B.V. | Ulegająca rozpadowi w ustach desmopresyna do zwiększania okresu snu niezakłócanego przez nokturię |
| US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
| US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
| CN102216304B (zh) | 2008-11-18 | 2014-07-09 | 弗·哈夫曼-拉罗切有限公司 | 二氢四氮杂苯并薁的烷基环己基醚 |
| US9532959B2 (en) | 2010-07-08 | 2017-01-03 | Wellesley Pharmaceuticals, Llc | Pharmaceutical formulation for reducing frequency of urination and method of use thereof |
| US10010514B2 (en) | 2010-07-08 | 2018-07-03 | Wellesley Pharmaceuticals, Llc | Pharmaceutical formulation for reducing frequency of urination and method of use thereof |
| US10105330B2 (en) | 2012-01-04 | 2018-10-23 | Wellesley Pharmaceuticals, Llc | Extended, delayed and immediate release formulation method of manufacturing and use thereof |
| US10278925B2 (en) | 2012-01-04 | 2019-05-07 | Wellesley Pharmaceuticals, Llc | Delayed-release formulations, methods of making and use thereof |
| SG11201500407XA (en) * | 2012-01-04 | 2015-03-30 | Wellesley Pharmaceuticals Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| CA2856673C (en) * | 2012-01-04 | 2018-08-21 | Wellesley Pharmaceuticals, Llc | Use of acetaminophen for reducing the frequency of urination |
| US10105328B2 (en) | 2014-06-06 | 2018-10-23 | Wellesley Pharmaceuticals, Llc | Composition for reducing frequency of urination, method of making and use thereof |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1251767B (de) | 1964-02-28 | 1968-04-18 | Dr Karl Thomae Gesellschaft mit beschrankter Haftung Biberach/Riß | Verfahren zur Herstellung von neuen m 6 Stellung substituierten 5 6 Dihydro-5oxo HH pyrido[2,3-b] [l,5]benzodiazepinen |
| US4680298A (en) | 1983-05-31 | 1987-07-14 | Schering Corporation | Tricyclic anti-allergy and use as anti-inflammatory agents |
| US4766108A (en) | 1986-12-04 | 1988-08-23 | Smith Kline Beckman Corporation | Tyr-Arg-vasopressin antagonists |
| US5055448A (en) | 1987-06-25 | 1991-10-08 | Medical College Of Ohio | Linear derivatives of arginine vasopressin antagonists |
| US4839355A (en) | 1987-09-09 | 1989-06-13 | Sterling Drug Inc. | Tricyclic-pyridinylquinoline compounds, their preparation and use |
| US5070187A (en) | 1989-11-03 | 1991-12-03 | Trustees Of Boston University | Pharmacologically effective antagonists of arginine-vasopressin |
| CA2048003A1 (en) | 1990-08-21 | 1992-02-22 | Serge Burner | Tricyclic pyridone derivatives |
| US5516774A (en) | 1993-07-29 | 1996-05-14 | American Cyanamid Company | Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| US5512563A (en) | 1993-07-29 | 1996-04-30 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
| US5420270A (en) | 1993-10-07 | 1995-05-30 | G. D. Searle & Co. | Aryl substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| DE69535486T2 (de) | 1994-06-15 | 2008-04-10 | Otsuka Pharmaceutical Co., Ltd. | Benzoheterocyclische Verbindungen verwendbar als Vasopressin- oder Oxytocin-Modulatoren |
| JPH0881460A (ja) | 1994-09-08 | 1996-03-26 | Yamanouchi Pharmaceut Co Ltd | 新規なテトラヒドロベンゾジアゼピン誘導体又はその塩 |
| US5521173A (en) | 1995-01-17 | 1996-05-28 | American Home Products Corporation | Tricyclic benzazepine vasopressin antagonists |
| US5536718A (en) | 1995-01-17 | 1996-07-16 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
| AR002459A1 (es) | 1995-01-17 | 1998-03-25 | American Cyanamid Co | Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades y unprocedimiento para su preparacion. |
| TW359669B (en) | 1995-12-15 | 1999-06-01 | Otsuka Pharma Co Ltd | Benzazepine derivatives |
| US5880122A (en) | 1996-11-01 | 1999-03-09 | American Home Products Corporation | 3-Carboxamide derivatives of 5H-pyrrolo 2,1-c! 1,4!-benzodiazepines |
| AU727654B2 (en) | 1997-06-13 | 2000-12-21 | Yamanouchi Pharmaceutical Co., Ltd. | Tricyclic pyrazole derivative |
| ATE277050T1 (de) | 1997-07-30 | 2004-10-15 | Wyeth Corp | Trizyclische vasopressin agoniste |
| US6194407B1 (en) | 1997-07-30 | 2001-02-27 | American Home Products Corporation | Tricyclic pyrido vasopressin agonists |
| US6297234B1 (en) | 1999-02-04 | 2001-10-02 | American Home Products Corporation | Arylthiophene vasopressin agonists |
| WO2000046228A2 (en) | 1999-02-04 | 2000-08-10 | American Home Products Corporation | Pyrrolobenzodiazepine carboxyamide vasopressin agonists |
| AU7615200A (en) | 1999-09-27 | 2001-04-30 | American Cyanamid Company | Vasopressin agonist formulation and process |
| MXPA02003190A (es) | 1999-09-27 | 2002-09-30 | American Cyanamid Co | Formulacion para portadores farmaceuticos. |
| GB0000079D0 (en) | 2000-01-05 | 2000-02-23 | Ferring Bv | Novel antidiuretic agents |
| GB0015601D0 (en) | 2000-06-26 | 2000-08-16 | Ferring Bv | Novel antidiuretic agents |
-
2002
- 2002-12-16 US US10/320,761 patent/US7138393B2/en not_active Expired - Fee Related
-
2003
- 2003-12-09 TW TW092134683A patent/TW200413355A/zh unknown
- 2003-12-15 AR ARP030104629A patent/AR042467A1/es not_active Application Discontinuation
- 2003-12-16 MX MXPA05006241A patent/MXPA05006241A/es active IP Right Grant
- 2003-12-16 DE DE60324018T patent/DE60324018D1/de not_active Expired - Lifetime
- 2003-12-16 JP JP2004565510A patent/JP2006514956A/ja active Pending
- 2003-12-16 BR BR0317383-6A patent/BR0317383A/pt not_active IP Right Cessation
- 2003-12-16 CA CA002508764A patent/CA2508764A1/en not_active Abandoned
- 2003-12-16 WO PCT/US2003/039897 patent/WO2004060894A1/en active Application Filing
- 2003-12-16 CN CNA2003801095935A patent/CN1745083A/zh active Pending
- 2003-12-16 ES ES03814820T patent/ES2312859T3/es not_active Expired - Lifetime
- 2003-12-16 AT AT03814820T patent/ATE410428T1/de not_active IP Right Cessation
- 2003-12-16 AU AU2003297127A patent/AU2003297127A1/en not_active Withdrawn
- 2003-12-16 EP EP03814820A patent/EP1572694B1/de not_active Expired - Lifetime
- 2003-12-16 DK DK03814820T patent/DK1572694T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| DK1572694T3 (da) | 2009-02-02 |
| US7138393B2 (en) | 2006-11-21 |
| EP1572694A1 (de) | 2005-09-14 |
| BR0317383A (pt) | 2005-11-16 |
| CA2508764A1 (en) | 2004-07-22 |
| CN1745083A (zh) | 2006-03-08 |
| AU2003297127A1 (en) | 2004-07-29 |
| ES2312859T3 (es) | 2009-03-01 |
| DE60324018D1 (de) | 2008-11-20 |
| ATE410428T1 (de) | 2008-10-15 |
| EP1572694B1 (de) | 2008-10-08 |
| JP2006514956A (ja) | 2006-05-18 |
| US20030134845A1 (en) | 2003-07-17 |
| AR042467A1 (es) | 2005-06-22 |
| MXPA05006241A (es) | 2005-08-19 |
| WO2004060894A1 (en) | 2004-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210047295A1 (en) | Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator | |
| JP7051703B2 (ja) | ピラゾロピリミジン誘導体 | |
| AU700637B2 (en) | Pyrimidine derivatives as 5ht2c-receptor antagonists | |
| JP4338305B2 (ja) | 三環系バソプレシンアゴニスト | |
| JP2022505591A (ja) | 新規駆虫薬化合物 | |
| EA021076B1 (ru) | Производные индола в качестве антагонистов рецептора crth2 | |
| JP4751398B2 (ja) | ハロゲン置換ベンゾジアゼピン誘導体 | |
| CN106459042A (zh) | 抗纤维化吡啶酮类 | |
| TW200413355A (en) | Biologically active vasopressin agonist metabolites | |
| JPH04235974A (ja) | 新規なイミダゾール誘導体、それらの製造法、得られる新規な中間体、それらの薬剤としての使用及びそれらを含有する製薬組成物 | |
| TW201024297A (en) | Heterocyclic inhibitors of histamine receptors for the treatment of disease | |
| AU2016372048A1 (en) | Heteroarylhydroxypyrimidinones as agonists of the APJ receptor | |
| EA011772B1 (ru) | 5,7-диаминопиразоло [4,3-d] пиримидины c ингибирующей pde - 5 активностью | |
| JP2011516599A (ja) | ニコチン性アセチルコリン受容体サブタイプα７のモジュレーターとしてのインドール類 | |
| TW201121966A (en) | Fused heterocyclic compounds as orexin receptor modulators | |
| EP1812450A2 (de) | Tgf-beta-inhibitoren | |
| WO2015155306A1 (en) | New trpa1 antagonists | |
| TW200821305A (en) | MGluR5 modulators | |
| MX2014011373A (es) | Inhibidores de diacilglicerol aciltransferasa 2. | |
| TW201130834A (en) | Heteroaromatic aryl triazole derivatives as PDE10A enzyme inhibitors | |
| TW200808800A (en) | MGluR5 modulators V | |
| TW200829251A (en) | Kinase inhibitors and methods for using the same | |
| EP3596051B1 (de) | Kondensierte bicyclische verbindungen, zusammensetzungen und anwendungen davon | |
| TW201202246A (en) | Heterocyclic compounds as JANUS kinase inhibitors | |
| WO2017064068A1 (en) | New trpa1 antagonists |